Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Lobeglitazone (sulfate) | 763108-62-9 | 99.6% | 578.61 | 5 MG
SDP

Catalog No. 5000361187
Encompass_Preferred

Lobeglitazone sulfate is a novel thiazolidinedione, functioning as an orally active agonist for PPAR with EC50 values of 137.4 nM for PPARγ and 546.3 nM for PPARα. It acts as an inhibitor for the ERK/JNK/Smad/NF-κB signaling pathway, demonstrating anti-inflammatory, anti-diabetic, anti-fibrotic, and anti-atherosclerotic properties.

  • Functions as an orally active agonist for PPAR
  • Inhibits ERK/JNK/Smad/NF-κB signaling pathway
  • Exhibits anti-inflammatory properties
  • Exhibits anti-diabetic properties
  • Exhibits anti-fibrotic properties
  • Exhibits anti-atherosclerotic properties
  • Increases glucose uptake in 3T3-L1 adipocytes and L6 muscle cells
  • Inhibits NO generation and pro-inflammatory cytokine expression

Catalog No. 50-003-61187 Supplier Medchemexpress LLC Supplier No. HY14928A5MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Lobeglitazone sulfate is a novel thiazolidinedione, functioning as an orally active agonist for PPAR with EC50 values of 137.4 nM for PPARγ and 546.3 nM for PPARα. It acts as an inhibitor for the ERK/JNK/Smad/NF-κB signaling pathway, demonstrating anti-inflammatory, anti-diabetic, anti-fibrotic, and anti-atherosclerotic properties.

  • Functions as an orally active agonist for PPAR
  • Inhibits ERK/JNK/Smad/NF-κB signaling pathway
  • Exhibits anti-inflammatory properties
  • Exhibits anti-diabetic properties
  • Exhibits anti-fibrotic properties
  • Exhibits anti-atherosclerotic properties
  • Increases glucose uptake in 3T3-L1 adipocytes and L6 muscle cells
  • Inhibits NO generation and pro-inflammatory cytokine expression

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.